Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,807 | 435 | 99.5% |
| Education | $34.69 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,153 | 72 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $883.59 | 39 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $706.61 | 37 | $0 (2020) |
| PFIZER INC. | $637.54 | 71 | $0 (2020) |
| Novo Nordisk Inc | $632.22 | 33 | $0 (2020) |
| Amgen Inc. | $479.54 | 25 | $0 (2019) |
| Lilly USA, LLC | $418.60 | 28 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $335.35 | 18 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $302.91 | 36 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $214.27 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $376.55 | 22 | Janssen Pharmaceuticals, Inc ($57.60) |
| 2019 | $2,136 | 125 | Janssen Pharmaceuticals, Inc ($416.61) |
| 2018 | $2,168 | 140 | Janssen Pharmaceuticals, Inc ($378.01) |
| 2017 | $2,161 | 151 | AstraZeneca Pharmaceuticals LP ($387.76) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/15/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Endocrinology | ||||||
| 03/10/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Endocrinology | ||||||
| 03/09/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 03/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/03/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), SPIRIVA RESPIMAT, COMBIVENT RESPIMAT | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: RESPIRATORY | ||||||
| 03/02/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: DIABETES | ||||||
| 02/25/2020 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/24/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Respiratory | ||||||
| 02/20/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/11/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Endocrinology | ||||||
| 02/10/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/05/2020 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: Oncology | ||||||
| 02/05/2020 | Novo Nordisk Inc | Tresiba (Drug), Victoza | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 02/04/2020 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Neuroscience | ||||||
| 01/31/2020 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: VACCINES | ||||||
| 01/29/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, SYNJARDY | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: DIABETES | ||||||
| 01/23/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/23/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/22/2020 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/08/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardiovascular | ||||||
| 01/08/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Diabetes | ||||||
| 12/16/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: DIABETES | ||||||
| 12/12/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/11/2019 | Mylan Specialty L.P. | Perforomist (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Respiratory and Allergy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 292 | 593 | $61,493 | $29,554 |
| 2022 | 10 | 412 | 774 | $88,595 | $41,838 |
| 2021 | 11 | 454 | 841 | $80,857 | $41,701 |
| 2020 | 10 | 524 | 968 | $98,157 | $46,045 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 148 | $33,152 | $11,955 | 36.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 104 | 303 | $13,638 | $10,587 | 77.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 32 | 32 | $7,776 | $4,201 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 26 | $3,926 | $1,443 | 36.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 12 | 12 | $720.00 | $501.96 | 69.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $689.00 | $407.81 | 59.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 40 | $1,440 | $375.98 | 26.1% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 19 | 19 | $152.00 | $81.51 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 184 | $41,216 | $15,650 | 38.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 98 | 328 | $14,763 | $10,507 | 71.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 40 | 40 | $9,720 | $5,403 | 55.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 44 | 58 | $8,758 | $3,792 | 43.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $6,734 | $3,219 | 47.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 40 | $2,120 | $1,226 | 57.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 13 | 13 | $2,288 | $1,042 | 45.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 53 | 60 | $2,160 | $521.20 | 24.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 12 | $636.00 | $371.66 | 58.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 25 | 25 | $200.00 | $107.99 | 54.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 166 | $37,184 | $14,653 | 39.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 137 | 414 | $18,634 | $13,570 | 72.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 39 | 39 | $9,477 | $5,380 | 56.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 30 | $4,530 | $2,129 | 47.0% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 41 | 41 | $2,460 | $1,707 | 69.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 16 | 16 | $1,840 | $1,394 | 75.7% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 12 | 12 | $2,112 | $1,024 | 48.5% |
About Dr. Hua Lu, MD
Dr. Hua Lu, MD is a Internal Medicine healthcare provider based in Lincoln, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962499897.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hua Lu, MD has received a total of $6,842 in payments from pharmaceutical and medical device companies, with $376.55 received in 2020. These payments were reported across 438 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($6,807).
As a Medicare-enrolled provider, Lu has provided services to 1,682 Medicare beneficiaries, totaling 3,176 services with total Medicare billing of $159,138. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Lincoln, RI
- Active Since 10/05/2005
- Last Updated 07/09/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962499897
Products in Payments
- XARELTO (Drug) $849.51
- SYMBICORT (Drug) $468.08
- JARDIANCE (Drug) $455.42
- FARXIGA (Drug) $398.02
- CHANTIX (Drug) $349.81
- INVOKANA (Drug) $303.02
- JANUVIA (Drug) $302.91
- ELIQUIS (Drug) $263.19
- Victoza (Drug) $260.62
- TRADJENTA (Drug) $212.05
- TRULICITY (Drug) $210.21
- Prolia (Biological) $201.01
- Ozempic (Drug) $169.34
- Tresiba (Drug) $131.20
- PREVNAR - 13 (Biological) $125.17
- TOUJEO (Drug) $122.35
- EMGALITY (Drug) $121.78
- Aimovig (Biological) $103.10
- ENTRESTO (Drug) $98.25
- VIAGRA (Drug) $95.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lincoln
Brock Cookman, D.o, D.O
Internal Medicine — Payments: $694,509
Dr. Ryan Martin, Md, MD
Internal Medicine — Payments: $414,185
Matthew Johnson, M.d, M.D
Internal Medicine — Payments: $307,471
Dr. Sherri Thomas, Do, DO
Internal Medicine — Payments: $100,336
Frank D'alessandro, Md Inc, MD INC
Internal Medicine — Payments: $86,860
Peter Gallagher, M.d, M.D
Internal Medicine — Payments: $83,162